Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082312 | SCV000114263 | uncertain significance | not provided | 2013-09-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086996 | SCV001009820 | likely benign | Bardet-Biedl syndrome | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000082312 | SCV001988951 | uncertain significance | not provided | 2019-06-28 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation as the last 4 amino acids are lost and replaced with 7 incorrect amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; This variant is associated with the following publications: (PMID: 15770229, 27491411) |
Prevention |
RCV003905070 | SCV004724432 | likely benign | BBS4-related disorder | 2020-02-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |